Acclaro Medical | $23,000,000 | (May 30, 2025)
FarmQA, Inc | $4,000,000 | (May 30, 2025)
KhiladiPro | $1,000,000 | (May 30, 2025)
Certified by Founder
Lodge
Tenvie Therapeutics
start up
United States
- South San Francisco, California
- 09/01/2025
- Unknown
- $200,000,000
Tenvie is a biotechnology company committed to engineering small molecules that transform the treatment of neurological diseases. The company’s foundation is purpose-built with a diverse portfolio of small molecules and a proven team of CNS drug developers to rapidly deliver multiple clinical assets. Tenvie is advancing a pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases. Its portfolio of wholly owned, highly brain-penetrant, and precision-designed peripherally restricted small molecules address three key drivers of disease: resolving inflammation, rescuing metabolic dysfunction, and restoring lysosomal function.
- Industry Biotechnology Research
- Website https://tenvie.com/
- LinkedIn https://www.linkedin.com/company/tenvie-therapeutics/
LovOn | $850,000 | (May 30, 2025)
Dream Park Immersive | $1,100,000 | (May 30, 2025)
Besample | $1,100,000 | (May 29, 2025)
Context | $11,000,000 | (May 29, 2025)
Palla Financial | $14,500,000 | (May 29, 2025)
Minset AI | Undisclosed Amount | (May 29, 2025)
Applied Computing | $12,125,376 | (May 29, 2025)
Orbitt Space | $1,000,000 | (May 29, 2025)
Velocity(UK) | $10,000,000 | (May 29, 2025)